Abstract
CV risk exponentially increases as the number of damaged organs increases The Systemic Hemodynamic Atherosclerotic Syndrome (SHATS) represents a novel conceptualization of the CV continuum focusing on simultaneous multi-organ alteration. This is the first study operationally defining SHATS and aimed at identifying its determinants. Left Ventricular Hypertrophy (echocardiography), Common Carotid Artery plaque and increased thickness (ultrasound), and Chronic Kidney Disease (estimated Glomerular Filtration Rate) indexed selective target organ damage. SHATS was operationally defined as their simultaneous presence in a patient. PWV was measured by Sphygmocor® and BP variability by 24 h ABPM. SHATS affected 19.9% of the 367 studied subjects. Subjects with SHATS had a similar prevalence in diabetes mellitus, but a greater prevalence of very stiff artery (84.9 vs 64.3%, p < 0.01) and use of antihypertensive medications. In the presence of similar office BP, SHATS was associated with higher 24 h SBP and lower 24 h DBP (a greater pulsatile pressure!), reduced nighttime SBP fall, and a twofold greater prevalence of reverse dipper status (48.2 vs 20.2%, p < 0.001). BMI (positive correlation) and DBP (negative correlation) were the only tr...Continue Reading
Citations
Jan 10, 2019·Hypertension·Iván Cavero-RedondoVicente Martínez-Vizcaíno
Feb 20, 2019·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Nicola Di DanieleAngelo Scuteri
May 17, 2019·The Journal of Clinical Hypertension·Telmo PereiraSonja Gose
Nov 27, 2019·The Journal of Clinical Hypertension·Angelo Scuteri, Antonella Mandas
Nov 27, 2019·The Journal of Clinical Hypertension·Upendra KaulWillem J Verberk
Apr 28, 2020·Hypertension·Qi KongYungao Wan
May 2, 2020·The Journal of Clinical Hypertension·Christina AntzaVasilios Kotsis
Dec 6, 2018·BMC Endocrine Disorders·Elin DybjerKatarina Nägga
Sep 13, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Jian-Jun LiuSu Chi Lim
Sep 27, 2020·Aging Clinical and Experimental Research·Tao ZhangJunfen Lin
Jul 16, 2019·Aging Clinical and Experimental Research·Angelo ScuteriFrancesco Cucca
May 10, 2020·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Valentina RovellaNicola Di Daniele
Oct 5, 2018·Journal of Alzheimer's Disease : JAD·Chendi CuiRachel H Mackey
Feb 11, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Xiaowei SongJian Wu
Nov 22, 2020·Aging Clinical and Experimental Research·Chong XuYawei Xu
Dec 5, 2020·Journal of Hypertension·Angelo ScuteriPedro G Cunha
Jan 28, 2021·Journal of Clinical Medicine·Alessandro P DelitalaFrancesco Cucca
Nov 20, 2020·Scientific Reports·Huisheng GeXixi Wu
Mar 16, 2021·The Journal of Clinical Hypertension·Alireza KhajaviFarzad Hadaegh
Mar 21, 2021·Acta Diabetologica·Jussi InkeriUNKNOWN FinnDiane Study Group
Dec 8, 2019·Progress in Cardiovascular Diseases·Kazuomi KarioJi-Guang Wang
Dec 31, 2019·Journal of the American Medical Directors Association·Edward G LakattaAngelo Scuteri
Jul 31, 2021·Scientific Reports·P M NabeelJayaraj Joseph